Showing results (521-530 of 1,933) with videos related to
Sort By:
Pageof 194
Annales Pharmaceutiques Francaises|April 2, 2003
[GMOs in food: risk assessment, scientific management and regulatory aspects]F Casse, F HervieuAnnales Pharmaceutiques Francaises|January 7, 2003
The Hydrogen-Bond: computational approaches and applications to drug designS Rey, P-A Carrupt, B TestaAnnales Pharmaceutiques Francaises|January 7, 2003
[Mechanism of action of tetrahydro-N, N-dimethyl-5, 5-diphenyl-3-furanemethanamine, a putative nootropic, anti-epileptic and antidepressant compound]A VamvakidèsAnnales Pharmaceutiques Francaises|October 16, 2002
[Methodologies used to screen for doping agents]M AudranAnnales Pharmaceutiques Francaises|October 16, 2002
[Certification of suitability of monographs of the European pharmacopoeia]A ArtigesAnnales Pharmaceutiques Francaises|October 16, 2002
[Selectivity of the reverse transcriptase inhibitors toward types 1 and 2 of human immunodeficiency virus (HIV)]J M J Tronchet, C Apparu-Turquois, N Laroze, et al.Annales Pharmaceutiques Francaises|February 18, 2003
[Synthesis and binding affinity of 3-aryl-7-hydroxycoumarins to human alpha and beta estrogen receptors]S Kirkiacharian, A T Lormier, M Resche-Rigon, et al.Annales Pharmaceutiques Francaises|February 18, 2003
[In vitro uranyle affinity of per (3,6-anhydro-2-O-carboxyméthyle)-alpha-cyclodextrin and conditions required for in vivo application]J C Debouzy, A Gadelle, H Tymen, et al.Annales Pharmaceutiques Francaises|June 7, 2002
[Crystallization and solid state properties of molecules of pharmaceutical interest]M BauerAnnales Pharmaceutiques Francaises|June 7, 2002
[Crystalline polymorphism of eflucimibe]J P Ribet, R Pena, A Chauvet, et al.Pageof 194